Kostaive

COVID-19 sa-mRNA Vaccine · Seqirus Netherlands B.V.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Kostaive, covering 2026-03-19 to 2026-07-13. Get the full timeline:

Most recent: EMA Authorised: Kostaive (COVID-19 sa-mRNA Vaccine) — Seqirus Netherlands B.V.